|
Condensed Consolidating Financial Statements Cash Flows (Details) (USD $) In Thousands, unless otherwise specified
|
6 Months Ended |
|
Jun. 30, 2014
|
Jun. 30, 2013
|
| Cash flows from operating activities: |
|
|
| Net cash provided (used) by operating activities |
$ 192,886 |
$ 236,253 |
| Cash flows from investing activities: |
|
|
| Acquisitions, net of cash acquired |
(2,026) |
(7,076) |
| Purchases of property and equipment |
(32,873) |
(72,135) |
| Proceeds from restricted cash |
0 |
20,004 |
| Net cash used by investing activities |
(34,899) |
(59,207) |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of debt |
492,500 |
100,000 |
| Repayment of long-term debt |
(312,500) |
(250,000) |
| Payment of financing costs |
(1,963) |
(2,347) |
| Proceeds from exercise of options |
4,944 |
1,928 |
| Proceeds from exercise of warrants |
3,453 |
0 |
| Tax benefit on option exercises |
3,993 |
9,479 |
| Payments of contingent consideration |
0 |
(23,203) |
| Net transactions with parent and affiliates |
0 |
0 |
| Distributions to non-controlling interest |
(25,800) |
(10,115) |
| Proceeds from restricted stock |
0 |
0 |
| Other |
(321) |
0 |
| Net cash (used) provided by financing activities |
164,306 |
(174,258) |
| Effect of foreign exchange on cash balances |
14 |
24 |
| Change in cash and cash equivalents |
322,307 |
2,812 |
| Cash and cash equivalents, beginning of period |
387,241 |
370,776 |
| Cash and cash equivalents, end of period |
709,548 |
373,588 |
|
Reportable Legal Entities [Member] | Catamaran Corporation [Member]
|
|
|
| Cash flows from operating activities: |
|
|
| Net cash provided (used) by operating activities |
152,832 |
60,033 |
| Cash flows from investing activities: |
|
|
| Acquisitions, net of cash acquired |
0 |
0 |
| Purchases of property and equipment |
(18) |
0 |
| Proceeds from restricted cash |
|
0 |
| Net cash used by investing activities |
(18) |
0 |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of debt |
492,500 |
100,000 |
| Repayment of long-term debt |
(312,500) |
(250,000) |
| Payment of financing costs |
(1,963) |
(2,347) |
| Proceeds from exercise of options |
7,026 |
2,744 |
| Proceeds from exercise of warrants |
3,453 |
|
| Tax benefit on option exercises |
0 |
0 |
| Payments of contingent consideration |
|
0 |
| Net transactions with parent and affiliates |
(114,078) |
51,480 |
| Distributions to non-controlling interest |
0 |
0 |
| Proceeds from restricted stock |
18,588 |
24,462 |
| Other |
0 |
|
| Net cash (used) provided by financing activities |
93,026 |
(73,661) |
| Effect of foreign exchange on cash balances |
14 |
24 |
| Change in cash and cash equivalents |
245,854 |
(13,604) |
| Cash and cash equivalents, beginning of period |
15,090 |
33,603 |
| Cash and cash equivalents, end of period |
260,944 |
19,999 |
|
Reportable Legal Entities [Member] | Guarantors [Member]
|
|
|
| Cash flows from operating activities: |
|
|
| Net cash provided (used) by operating activities |
591,827 |
292,494 |
| Cash flows from investing activities: |
|
|
| Acquisitions, net of cash acquired |
(2,026) |
0 |
| Purchases of property and equipment |
(18,671) |
(71,919) |
| Proceeds from restricted cash |
|
20,004 |
| Net cash used by investing activities |
(20,697) |
(51,915) |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of debt |
0 |
0 |
| Repayment of long-term debt |
0 |
0 |
| Payment of financing costs |
0 |
0 |
| Proceeds from exercise of options |
(2,057) |
(806) |
| Proceeds from exercise of warrants |
0 |
|
| Tax benefit on option exercises |
3,955 |
9,472 |
| Payments of contingent consideration |
|
(18,338) |
| Net transactions with parent and affiliates |
(483,936) |
(187,511) |
| Distributions to non-controlling interest |
0 |
0 |
| Proceeds from restricted stock |
(18,079) |
(23,886) |
| Other |
(321) |
|
| Net cash (used) provided by financing activities |
(500,438) |
(221,069) |
| Effect of foreign exchange on cash balances |
0 |
0 |
| Change in cash and cash equivalents |
70,692 |
19,510 |
| Cash and cash equivalents, beginning of period |
350,889 |
303,833 |
| Cash and cash equivalents, end of period |
421,581 |
323,343 |
|
Reportable Legal Entities [Member] | Non-Guarantors [Member]
|
|
|
| Cash flows from operating activities: |
|
|
| Net cash provided (used) by operating activities |
(314,610) |
40,384 |
| Cash flows from investing activities: |
|
|
| Acquisitions, net of cash acquired |
0 |
(7,076) |
| Purchases of property and equipment |
(14,184) |
(216) |
| Proceeds from restricted cash |
|
0 |
| Net cash used by investing activities |
(14,184) |
(7,292) |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of debt |
0 |
0 |
| Repayment of long-term debt |
0 |
0 |
| Payment of financing costs |
0 |
0 |
| Proceeds from exercise of options |
(25) |
(10) |
| Proceeds from exercise of warrants |
0 |
|
| Tax benefit on option exercises |
38 |
7 |
| Payments of contingent consideration |
|
(4,865) |
| Net transactions with parent and affiliates |
335,051 |
(30,742) |
| Distributions to non-controlling interest |
0 |
0 |
| Proceeds from restricted stock |
(509) |
(576) |
| Other |
0 |
|
| Net cash (used) provided by financing activities |
334,555 |
(36,186) |
| Effect of foreign exchange on cash balances |
0 |
0 |
| Change in cash and cash equivalents |
5,761 |
(3,094) |
| Cash and cash equivalents, beginning of period |
21,262 |
33,340 |
| Cash and cash equivalents, end of period |
27,023 |
30,246 |
|
Consolidations [Member]
|
|
|
| Cash flows from operating activities: |
|
|
| Net cash provided (used) by operating activities |
(237,163) |
(156,658) |
| Cash flows from investing activities: |
|
|
| Acquisitions, net of cash acquired |
0 |
0 |
| Purchases of property and equipment |
0 |
0 |
| Proceeds from restricted cash |
|
0 |
| Net cash used by investing activities |
0 |
0 |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of debt |
0 |
0 |
| Repayment of long-term debt |
0 |
0 |
| Payment of financing costs |
0 |
0 |
| Proceeds from exercise of options |
0 |
0 |
| Proceeds from exercise of warrants |
0 |
|
| Tax benefit on option exercises |
0 |
0 |
| Payments of contingent consideration |
|
0 |
| Net transactions with parent and affiliates |
262,963 |
166,773 |
| Distributions to non-controlling interest |
(25,800) |
(10,115) |
| Proceeds from restricted stock |
0 |
0 |
| Other |
0 |
|
| Net cash (used) provided by financing activities |
237,163 |
156,658 |
| Effect of foreign exchange on cash balances |
0 |
0 |
| Change in cash and cash equivalents |
0 |
0 |
| Cash and cash equivalents, beginning of period |
0 |
0 |
| Cash and cash equivalents, end of period |
$ 0 |
$ 0 |